{
    "clinical_study": {
        "@rank": "53522", 
        "arm_group": {
            "arm_group_label": "DTI patients", 
            "description": "Male or non pregnant female over 18 years who are undergoing surgery and using sevoflurane as the anesthetic agent with Mallampati score III or IV"
        }, 
        "brief_summary": {
            "textblock": "This is a prospective, open-label, multicenter, post marketing, observational study to\n      investigate the effectiveness of Sevoflurane anaesthesia in difficult to intubate  Egyptian\n      patients."
        }, 
        "brief_title": "Investigation of the Effectiveness of Sevoflurane Anaesthesia in Difficult to Intubate Egyptian Patients", 
        "completion_date": {
            "#text": "April 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Patients Suspected to Have Difficult Intubation", 
        "detailed_description": {
            "textblock": "This study aims to evaluate the effectiveness of sevoflurane in intubation in Egyptian, non\n      obstetric patients undergoing surgery who suffer from suspected difficult intubation.\n\n      The study will collect clinical data from approximately 97 difficult to intubation patients\n      who has been administered sevoflurane during anesthesia induction in the operating room. The\n      intubation success rate and duration of intubation will be calculated."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        1. Male or non-pregnant female over 18 years who are undergoing surgery and using\n        sevoflurane as the anesthetic agent with Mallampati score III or IV\n\n        2. Patients with at least one of the below criteria:\n\n          1. Anatomic\n\n               -  micrognathia - small mandible\n\n               -  macroglossia - large tongue\n\n               -  short or fixed neck\n\n               -  anterior vocal cords\n\n          2. Trauma- neck or face\n\n          3. Burns- airway edema\n\n          4. Infections - edema\n\n               -  Retropharyngeal abscess\n\n               -  Submandibular abscess\n\n               -  epiglottitis\n\n               -  laryngotracheobronchitis (croup)\n\n          5. Neoplasms; e.g., laryngeal tumors\n\n          6. Rheumatoid arthritis - TMJ immobility\n\n          7. Diabetes mellitus\n\n          8. Waxy skin - palm test\n\n          9. Decreased FRC - rapid desaturation(due to displaced diaphragm, Increased closing\n             capacity and small airway closure, increased oxygen consumption)\n\n         10. airway closure in supine position\n\n         11. Morbid obesity (BMI >35)\n\n         12. Airway edema\n\n         13. Laryngospasm\n\n         14. Edentulous patients - no cheeks.\n\n        3. Patients willing to sign informed consent\n\n        Exclusion Criteria:\n\n          1. Patients with present use of opioids and/or narcotic dependent.\n\n          2. Patients with known sensitivity to sevoflurane or to other halogenated agents.\n\n          3. Patients with known or suspected genetic susceptibility to malignant hyperthermia.\n\n          4. Alcohol addictive patients.\n\n          5. Patients with Renal insufficiency (baseline serum creatinine greater than 1.5 mg/dL)\n\n          6. Patient is a pregnant or breastfeeding female"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Hospitals with operation theaters"
            }
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 12, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01749631", 
            "org_study_id": "P13-805"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Anesthetics", 
                "Sevoflurane"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Patients suspected to have difficult  intubation", 
        "lastchanged_date": "February 27, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Cairo", 
                        "country": "Egypt"
                    }, 
                    "name": "Site Reference ID/Investigator# 87893"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 87893", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cairo", 
                        "country": "Egypt"
                    }, 
                    "name": "Site Reference ID/Investigator# 87894"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 87894", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cairo", 
                        "country": "Egypt"
                    }, 
                    "name": "Site Reference ID/Investigator# 87895"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 87895", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cairo", 
                        "country": "Egypt"
                    }, 
                    "name": "Site Reference ID/Investigator# 87913"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 87913", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cairo", 
                        "country": "Egypt"
                    }, 
                    "name": "Site Reference ID/Investigator# 87897"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 87897", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cairo", 
                        "country": "Egypt"
                    }, 
                    "name": "Site Reference ID/Investigator# 87914"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 87914", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Giza", 
                        "country": "Egypt", 
                        "zip": "12311"
                    }, 
                    "name": "Site Reference ID/Investigator# 77733"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 77733", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Giza", 
                        "country": "Egypt"
                    }, 
                    "name": "Site Reference ID/Investigator# 87896"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 87896", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": "Egypt"
        }, 
        "number_of_groups": "1", 
        "official_title": "A Prospective, 1 Year, Open-label, Multicenter, Post Marketing, Observational Study to Investigate the Value of Sevoflurane Anaesthesia of Difficult to Intubation Patients in Egyptian Population", 
        "overall_contact": {
            "email": "rasha.eldessouky@abbott.com", 
            "last_name": "Rasha   Eldessouky, MD"
        }, 
        "overall_contact_backup": {
            "email": "shimaa.magdy@abbott.com", 
            "last_name": "Shimaa  Magdy, BS Pharm"
        }, 
        "overall_official": {
            "affiliation": "Abbott (Egypt)", 
            "last_name": "Rasha  Eldessouky", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Egypt: Ministry of Health and Population"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "- The primary endpoint is the rate of intubation success (the percentage of patients for whom intubation was successful). A success is defined as intubation achieved in less than four attempts.\nPatient is either considered a success or failure. Number of Intubation Attempts (following the guidelines of ASA) is a maximum of three attempts after which patient will be considered a failure", 
            "measure": "The rate of intubation success (the percentage of patients for whom intubation was successful)", 
            "safety_issue": "No", 
            "time_frame": "Day 1"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01749631"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "The mean duration of induction (in seconds) defined as the time required to reach a Ramsay score of 5 from start of induction", 
                "measure": "The mean duration of induction (in seconds)", 
                "safety_issue": "No", 
                "time_frame": "Day 1"
            }, 
            {
                "description": "The mean duration of intubation procedure (in minutes) defined as the time from intubation start to the completion of the intubation process(from tube introduction to PETCO2)", 
                "measure": "The mean duration of intubation procedure (in minutes)", 
                "safety_issue": "No", 
                "time_frame": "Day 1"
            }, 
            {
                "description": "Percentage of patients who experienced complications resulting from intubation procedure (including but not limited to: bleeding, salivating, lung aspiration)", 
                "measure": "Percentage of patients who experienced complications resulting from intubation procedure", 
                "safety_issue": "Yes", 
                "time_frame": "Day 1"
            }, 
            {
                "description": "Percentage of patients who experienced difficulties related to the use of sevoflurane (including but not limited to: vocal cords adduction, coughing, movements, apnea episodes)", 
                "measure": "Percentage of patients who experienced difficulties related to the use of sevoflurane", 
                "safety_issue": "Yes", 
                "time_frame": "Day 1"
            }, 
            {
                "description": "The mean number of intubation attempts", 
                "measure": "The mean number of intubation attempts", 
                "safety_issue": "No", 
                "time_frame": "Day 1"
            }
        ], 
        "source": "AbbVie", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "AbbVie (prior sponsor, Abbott)", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "October 2012", 
        "study_design": "Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "February 2014"
    }
}